The expression of the miR-25/93/106b family of micro-RNAs in the adipose tissue of women with polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 12, 2014, Pages E2754-E2761

  Wu, Hsiao Li ^a   Heneidi, Saleh ^a   Chuang, Tung Yueh ^a   Diamond, Michael P ^a   Layman, Lawrence C ^a,b   Azziz, Ricardo ^a   Chen, Yen Hao ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b AUGUSTA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; MICRORNA; MICRORNA 106B; MICRORNA 25; MICRORNA 93; UNCLASSIFIED DRUG; MCM7 PROTEIN, HUMAN; MINICHROMOSOME MAINTENANCE PROTEIN 7; MIRN106 MICRORNA, HUMAN; MIRN25 MICRORNA, HUMAN; MIRN93 MICRORNA, HUMAN;

3T3 CELL LINE; ADIPOSE TISSUE; ANIMAL CELL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; EPIGENETICS; FEMALE; GENE; GENE CLUSTER; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RESISTANCE; MCM7 GENE; MOUSE; NONHUMAN; OVARY POLYCYSTIC DISEASE; ANIMAL; BIOSYNTHESIS; CELL DIFFERENTIATION; DRUG EFFECTS; GENE EXPRESSION; GENETICS; METABOLISM;

3T3-L1 CELLS; ADIPOSE TISSUE; ANIMALS; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION; HUMANS; INSULIN RESISTANCE; MICE; MICRORNAS; MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 7; POLYCYSTIC OVARY SYNDROME;

EID: 84916598840     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-4435     Document Type: Article

References (27)

1. Azziz R, Carmina E, Dewailly D, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91:456-488.
2. Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1998;83:2694-2698.
3. Shaw LJ, Bairey Merz CN, Azziz R, et al. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab. 2008;93:1276-1284.
4. Ovalle F, Azziz R. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertil Steril. 2002;77:1095-1105.
5. Ciaraldi TP, el-Roeiy A, Madar Z, Reichart D, Olefsky JM, Yen SS. Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J Clin Endocrinol Metab. 1992;75:577-583.
6. Rosenbaum D, Haber RS, Dunaif A. Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes. Am J Physiol. 1993;264:E197-E202.
7. Ciaraldi TP. Molecular defects of insulin action in the polycystic ovary syndrome: possible tissue specificity. J Pediatr Endocrinol Metab. 2000;13(suppl 5):1291-1293.
8. Ciaraldi TP, Morales AJ, Hickman MG, Odom-Ford R, Olefsky JM, Yen SS. Cellular insulin resistance in adipocytes from obese polycystic ovary syndrome subjects involves adenosine modulation of insulin sensitivity. J Clin Endocrinol Metab. 1997;82:1421-1425.
9. Marsden PJ, Murdoch AP, Taylor R. Tissue insulin sensitivity and body weight in polycystic ovary syndrome. Clin Endocrinol (Oxf). 2001;55:191-199.
10. Biyasheva A, Legro RS, Dunaif A, Urbanek M. Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2. J Clin Endocrinol Metab. 2009;94:2617-2625.
11. Lord J, Thomas R, Fox B, Acharya U, Wilkin T. The effect of metformin on fat distribution and the metabolic syndrome in women with polycystic ovary syndrome - a randomised, double-blind, placebo-controlled trial. BJOG. 2006;113:817-824.
12. Chen YH, Heneidi S, Lee JM, et al. miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance. Diabetes. 2013;62:2278-2286.
13. Herrera BM, Lockstone HE, Taylor JM, et al. Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes. Diabetologia. 2010;53:1099-1109.
14. Long J, Wang Y, Wang W, Chang BH, Danesh FR. Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions. J Biol Chem. 2010;285:23457-23465.
15. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89:2745-2749.
16. Malcolm CE, Cumming DC. Does anovulation exist in eumenorrheic women? Obstet Gynecol. 2003;102:317-318.
17. Katsuki A, Sumida Y, Gabazza EC, et al. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care. 2001;24:362-365.
18. Azziz R. Fat biopsy procedure with Dr Ricardo Azziz. [video], 2012. https://www.youtube.com/watch?v=GQ5ULpW7oDg. Accessed April 12, 2012.
19. Student AK, Hsu RY, Lane MD. Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes. J Biol Chem. 1980;255:4745-4750.
20. Ma J, Nakagawa Y, Kojima I, Shibata H. Prolonged insulin stimulation down-regulates GLUT4 through oxidative stress-mediated retromer inhibition by a protein kinase CK2-dependent mechanism in 3T3-L1 adipocytes. J Biol Chem. 2014;289:133-142.
21. Griffiths-Jones S. Annotating noncoding RNA genes. Annu Rev Genomics Hum Genet. 2007;8:279-298.
22. Petrocca F, Visone R, Onelli MR, et al. E2F1-regulated microRNAs impair TGFβ-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell. 2008;13:272-286.
23. Wang J, Xiang G, Mitchelson K, Zhou Y. Microarray profiling of monocytic differentiation reveals miRNA-mRNA intrinsic correlation. J Cell Biochem. 2011;112:2443-2453.
24. Chuang TD, Luo X, Panda H, Chegini N. miR-93/106b and their host gene, MCM7, are differentially expressed in leiomyomas and functionally target F3 and IL-8. Mol Endocrinol. 2012;26:1028-1042.
25. van Kouwenhove M, Kedde M, Agami R. MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer. 2011;11:644-656.
26. Monteys AM, Spengler RM, Wan J, et al. Structure and activity of putative intronic miRNA promoters. RNA. 2010;16:495-505.
27. Yang L, Cheng P, Chen C, et al. miR-93/Sp7 function loop mediates osteoblast mineralization. J Bone Miner Res. 2012;27:1598-1606.